Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
SK Chemicals Co., Ltd.
Age
19–45
Sex
MALE
Healthy volunteers
Accepted
You may be eligible if
Participants who have fully understood this clinical trial via detailed explanation, are willing to voluntarily participate in this study, and agree to give written informed consent which is confirmed from IRB.
Healthy male participants aged between 19 and 45 years at screening
Those whose body weight is over 50kg, and BMI is between 18.0 and 27.0
Participants who have demonstrated at least a 100 percent (%) increase in dermal blood flow in 30 minutes after capsaicin challenge as part of the screening procedures.
You may not be if
Those who have a clinically significant disease of liver, kidney, digestive, respiratory, endocrine, neurologic, blood/tumor, cardiovascular system, or history of those diseases
Those who have a history of hypersensitivity or clinically significant hypersensitivity reactions to drugs (containing Topiramate etc.)
Those who have a hereditary galactose intolerance, lapp lactase deficiency or glucose-galactose malabsorption syndrome
Those who have irritating skin, wounds, eczema, and wounds on the area where capsaicin is applied
